The market is expanding as life sciences organizations, clinical laboratories, software developers, and research institutions transition toward automated platforms that handle immense genomic datasets, lower sequencing interpretation costs, and accelerate therapeutic discovery. Growth is supported by the rapid accumulation of multi-omics data, public and private R&D funding, expanding...